3,4-dihydroxyphenylacetic acid has been researched along with vasoactive intestinal peptide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moroji, T; Nakamura, H; Nohara, S; Okada, A | 1 |
| Izumi, J; Schiöth, HB; Watanobe, H | 1 |
| Celik, M; Korkmaz, OT; Oncü, EM; Sahintürk, V; Tunçel, M; Tunçel, N | 1 |
3 other study(ies) available for 3,4-dihydroxyphenylacetic acid and vasoactive intestinal peptide
| Article | Year |
|---|---|
[Effects of whole-body vibration exposure on DOPAC and VIP-like immunoreactivity in the rat brain].
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Male; Rats; Rats, Inbred Strains; Stress, Physiological; Vasoactive Intestinal Peptide; Vibration | 1992 |
Pivotal roles of alpha-melanocyte-stimulating hormone and the melanocortin 4 receptor in leptin stimulation of prolactin secretion in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-MSH; Animals; beta-Endorphin; Brain; Dopamine; Dose-Response Relationship, Drug; Fasting; gamma-MSH; Hydroxyindoleacetic Acid; Hypothalamic Hormones; Immune Sera; Injections, Intraventricular; Leptin; Male; Neuropeptides; Peptides, Cyclic; Pituitary Gland; Prolactin; Prolactin-Releasing Hormone; Rats; Rats, Wistar; Receptor, Melanocortin, Type 3; Receptor, Melanocortin, Type 4; Receptors, Corticotropin; Serotonin; Vasoactive Intestinal Peptide | 2003 |
Vasoactive intestinal peptide (VIP) treatment of Parkinsonian rats increases thalamic gamma-aminobutyric acid (GABA) levels and alters the release of nerve growth factor (NGF) by mast cells.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Female; gamma-Aminobutyric Acid; Heparin; Male; Mast Cells; Microdialysis; Nerve Growth Factor; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Serotonin; Thalamus; Vasoactive Intestinal Peptide | 2010 |